List Name |
Annotation |
Enrichment |
p-value |
patterning of blood vessels |
AmiGO Browser |
33.71 |
9.33e-05 |
sterol biosynthetic process |
AmiGO Browser |
16.51 |
1.06e-04 |
cholesterol biosynthetic process |
AmiGO Browser |
16.40 |
8.28e-04 |
embryonic development |
AmiGO Browser |
4.08 |
9.36e-04 |
embryonic pattern specification |
AmiGO Browser |
14.80 |
1.12e-03 |
steroid biosynthetic process |
AmiGO Browser |
8.17 |
1.55e-03 |
germ cell migration |
AmiGO Browser |
28.90 |
2.14e-03 |
cell growth |
AmiGO Browser |
4.37 |
2.84e-03 |
sterol metabolic process |
AmiGO Browser |
6.92 |
2.84e-03 |
B cell differentiation |
AmiGO Browser |
10.65 |
2.90e-03 |
regulation of cell size |
AmiGO Browser |
4.30 |
3.04e-03 |
branching morphogenesis of a tube |
AmiGO Browser |
9.34 |
4.20e-03 |
morphogenesis of a branching structure |
AmiGO Browser |
9.19 |
4.38e-03 |
anatomical structure formation |
AmiGO Browser |
3.82 |
0.01 |
leukocyte differentiation |
AmiGO Browser |
4.42 |
0.01 |
tube morphogenesis |
AmiGO Browser |
6.07 |
0.01 |
cholesterol metabolic process |
AmiGO Browser |
5.72 |
0.02 |
growth |
AmiGO Browser |
3.01 |
0.02 |
lipid biosynthetic process |
AmiGO Browser |
3.38 |
0.02 |
regulation of apoptosis |
AmiGO Browser |
2.32 |
0.02 |
hemopoiesis |
AmiGO Browser |
3.34 |
0.02 |
regulation of programmed cell death |
AmiGO Browser |
2.30 |
0.02 |
B cell activation |
AmiGO Browser |
5.28 |
0.02 |
apoptosis |
AmiGO Browser |
2.06 |
0.02 |
programmed cell death |
AmiGO Browser |
2.05 |
0.02 |
angiogenesis |
AmiGO Browser |
3.82 |
0.02 |
hemopoietic or lymphoid organ development |
AmiGO Browser |
3.13 |
0.02 |
pattern specification process |
AmiGO Browser |
3.71 |
0.02 |
endosome transport |
AmiGO Browser |
8.09 |
0.03 |
cytokine and chemokine mediated signaling pathway |
AmiGO Browser |
8.09 |
0.03 |
lymphocyte differentiation |
AmiGO Browser |
4.74 |
0.03 |
cell differentiation |
AmiGO Browser |
1.63 |
0.03 |
cellular developmental process |
AmiGO Browser |
1.63 |
0.03 |
steroid metabolic process |
AmiGO Browser |
3.46 |
0.03 |
immune system development |
AmiGO Browser |
2.92 |
0.03 |
death |
AmiGO Browser |
1.93 |
0.03 |
cell death |
AmiGO Browser |
1.93 |
0.03 |
cytoskeleton-dependent intracellular transport |
AmiGO Browser |
4.37 |
0.03 |
DNA-dependent DNA replication |
AmiGO Browser |
4.33 |
0.03 |
blood vessel morphogenesis |
AmiGO Browser |
3.26 |
0.04 |
gastrulation |
AmiGO Browser |
6.63 |
0.04 |
tube development |
AmiGO Browser |
3.99 |
0.04 |
mesodermal cell differentiation |
AmiGO Browser |
22.47 |
0.04 |
mesodermal cell fate commitment |
AmiGO Browser |
22.47 |
0.04 |
polyamine biosynthetic process |
AmiGO Browser |
22.47 |
0.04 |
cell migration |
AmiGO Browser |
2.63 |
0.04 |
histone methylation |
AmiGO Browser |
20.23 |
0.05 |
rRNA transcription |
AmiGO Browser |
20.23 |
0.05 |
dendrite morphogenesis |
AmiGO Browser |
20.23 |
0.05 |
arginine catabolic process |
AmiGO Browser |
20.23 |
0.05 |
positive regulation of apoptosis |
AmiGO Browser |
2.55 |
0.05 |
excretion |
AmiGO Browser |
5.62 |
0.05 |
DNA replication |
AmiGO Browser |
2.92 |
0.05 |
positive regulation of programmed cell death |
AmiGO Browser |
2.53 |
0.05 |
cell morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
cellular structure morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
regulation of progression through S phase |
AmiGO Browser |
18.39 |
0.05 |
positive regulation of lymphocyte mediated immunity |
AmiGO Browser |
18.39 |
0.05 |
endosome to lysosome transport |
AmiGO Browser |
18.39 |
0.05 |
positive regulation of leukocyte mediated immunity |
AmiGO Browser |
18.39 |
0.05 |
regulation of S phase of mitotic cell cycle |
AmiGO Browser |
18.39 |
0.05 |
blood vessel development |
AmiGO Browser |
2.86 |
0.05 |
reproductive structure development |
AmiGO Browser |
5.39 |
0.05 |
gonad development |
AmiGO Browser |
5.39 |
0.05 |
alcohol metabolic process |
AmiGO Browser |
2.48 |
0.05 |
vasculature development |
AmiGO Browser |
2.81 |
0.06 |
positive regulation of immune effector process |
AmiGO Browser |
16.86 |
0.06 |
development of primary sexual characteristics |
AmiGO Browser |
5.12 |
0.06 |
regulation of embryonic development |
AmiGO Browser |
15.56 |
0.06 |
positive regulation of adaptive immune response |
AmiGO Browser |
15.56 |
0.06 |
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
15.56 |
0.06 |
protein stabilization |
AmiGO Browser |
15.56 |
0.06 |
anatomical structure morphogenesis |
AmiGO Browser |
1.66 |
0.06 |
regulation of production of molecular mediator of immune response |
AmiGO Browser |
14.45 |
0.07 |
heparan sulfate proteoglycan metabolic process |
AmiGO Browser |
14.45 |
0.07 |
cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
anterior/posterior axis specification |
AmiGO Browser |
14.45 |
0.07 |
regulation of cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
3.19 |
0.07 |
regulation of T cell mediated immunity |
AmiGO Browser |
13.48 |
0.07 |
isoprenoid biosynthetic process |
AmiGO Browser |
13.48 |
0.07 |
response to fungus |
AmiGO Browser |
12.64 |
0.08 |
arginine metabolic process |
AmiGO Browser |
12.64 |
0.08 |
L-amino acid transport |
AmiGO Browser |
12.64 |
0.08 |
regulation of lymphocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
urea cycle intermediate metabolic process |
AmiGO Browser |
11.90 |
0.08 |
regulation of leukocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
gastrulation (sensu Mammalia) |
AmiGO Browser |
11.90 |
0.08 |
polyamine metabolic process |
AmiGO Browser |
11.90 |
0.08 |
cell development |
AmiGO Browser |
1.55 |
0.08 |
meiosis |
AmiGO Browser |
4.17 |
0.08 |
M phase of meiotic cell cycle |
AmiGO Browser |
4.17 |
0.08 |
regulation of cell growth |
AmiGO Browser |
2.93 |
0.08 |
system development |
AmiGO Browser |
1.46 |
0.08 |
meiotic cell cycle |
AmiGO Browser |
4.13 |
0.09 |
lysosomal transport |
AmiGO Browser |
11.24 |
0.09 |
S phase of mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
negative regulation of progression through mitotic cell cycle |
AmiGO Browser |
11.24 |
0.09 |
S phase |
AmiGO Browser |
11.24 |
0.09 |
gastrulation (sensu Vertebrata) |
AmiGO Browser |
10.65 |
0.09 |
regulation of T cell receptor signaling pathway |
AmiGO Browser |
10.65 |
0.09 |
gastrulation with mouth forming second |
AmiGO Browser |
10.65 |
0.09 |
induction of apoptosis |
AmiGO Browser |
2.37 |
0.09 |
induction of programmed cell death |
AmiGO Browser |
2.36 |
0.09 |
negative regulation of apoptosis |
AmiGO Browser |
2.35 |
0.09 |
axon guidance |
AmiGO Browser |
3.89 |
0.09 |
fructose metabolic process |
AmiGO Browser |
10.11 |
0.09 |
regulation of immune effector process |
AmiGO Browser |
10.11 |
0.09 |
organ development |
AmiGO Browser |
1.52 |
0.09 |
negative regulation of programmed cell death |
AmiGO Browser |
2.33 |
0.10 |
sex differentiation |
AmiGO Browser |
3.82 |
0.10 |
regulation of protein stability |
AmiGO Browser |
9.63 |
0.10 |
regulation of antigen receptor-mediated signaling pathway |
AmiGO Browser |
9.19 |
0.10 |
vacuolar transport |
AmiGO Browser |
9.19 |
0.10 |
microtubule-based movement |
AmiGO Browser |
3.68 |
0.10 |